| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/1994 | CA2146164A1 Novel 17.beta.-substituted 4-azaandrostane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 04/14/1994 | CA2146163A1 Heterocyclic amines calmodulin antagonist properties |
| 04/14/1994 | CA2146152A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives; process for preparing the same and drugs containing them |
| 04/14/1994 | CA2146126A1 Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor |
| 04/14/1994 | CA2145867A1 Novel asymmetrically substituted bisnaphthalimides |
| 04/14/1994 | CA2145746A1 5-ht4 antagonists |
| 04/14/1994 | CA2145681A1 Method for antogonizing inositol 1,4,5-triphosphate |
| 04/14/1994 | CA2145680A1 Inhibition of cyst formation by cytoskeletal specific drugs |
| 04/14/1994 | CA2145521A1 Method and composition for the treatment of parkinson's disease |
| 04/14/1994 | CA2144155A1 Ibuprofen-h2 antagonist combinations |
| 04/14/1994 | CA2144152A1 Ibuprofen-caffine combinations |
| 04/14/1994 | CA2143117A1 Tocolytic oxytocin receptor antagonists |
| 04/14/1994 | CA2142974A1 Benzo-fused lactams promote release of growth hormone |
| 04/14/1994 | CA2142727A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3- pyridinecarboxyaldehyde-o-methyl-oxime |
| 04/14/1994 | CA2142706A1 Benzo-fused lactams promote release of growth hormone |
| 04/14/1994 | CA2136451A1 Novel vitamin d analogues |
| 04/14/1994 | CA2125287A1 Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives |
| 04/14/1994 | CA2124340A1 Lithium salt of 2-0-alkylascorbic acid |
| 04/14/1994 | CA2121596A1 Novel thiosemicarbazonethiones |
| 04/13/1994 | EP0592367A2 Phosphono/biaryl substituted dipeptide derivatives |
| 04/13/1994 | EP0592348A1 Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use |
| 04/13/1994 | EP0592167A1 Antibiotic pyrrolidinylthiopenem derivatives |
| 04/13/1994 | EP0592010A2 Topical compositions containing LYCD and other topically active medicinal ingredients |
| 04/13/1994 | EP0591937A1 Use of isoquinolinone derivatives for treating hyperlipoproteinemia |
| 04/13/1994 | EP0591891A2 Benzimidazole derivatives as Angiotensin II antagonists |
| 04/13/1994 | EP0591857A1 Use of L-carnitine and acyl L-carnitines for the long-term treatment of non-insulin-dependent diabetic patients |
| 04/13/1994 | EP0591852A1 Product with reduces H2S-content and method for its production |
| 04/13/1994 | EP0591808A1 Quinolonecarboxylic acids |
| 04/13/1994 | EP0591807A2 Biologically active polymers |
| 04/13/1994 | EP0591781A1 Substituted carbamoylpyrazolines, process for their preparation and their use as pesticides |
| 04/13/1994 | EP0591765A2 1,4-Dihydropyridine-alkoxy and alkylamino esters as antihypertensives |
| 04/13/1994 | EP0591710A1 Injection solutions containing mesna |
| 04/13/1994 | EP0591584A1 N-Alkyl-3-phenyl-3-(2-halo-substituted phenoxy)Propylamines as norepinephrine uptake inhibitors |
| 04/13/1994 | EP0591583A1 Benzo (f) quinolinones as 5-alpha-reductase inhibitors |
| 04/13/1994 | EP0591546A1 External preparation for curing damage to skin |
| 04/13/1994 | EP0591529A1 Novel benzodiazepine derivative |
| 04/13/1994 | EP0591528A1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME |
| 04/13/1994 | EP0591492A1 A pharmaceutical composition containing a defined lipid system |
| 04/13/1994 | EP0591486A1 Immuno-activating and hence anti-viral effect of 4- 3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazole compounds |
| 04/13/1994 | EP0591458A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 04/13/1994 | EP0591446A1 Method for treating helicobacter pylori gastritis |
| 04/13/1994 | EP0591434A1 Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| 04/13/1994 | EP0591426A1 Sigma receptor ligands and the use thereof |
| 04/13/1994 | EP0591424A1 Extended-release form of diltiazem |
| 04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591395A1 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 04/13/1994 | EP0591389A1 Dosage form for a delayed drug delivery |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591378A1 Method of preventing and treating chemotherapy-induced alopecia |
| 04/13/1994 | EP0591374A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 04/13/1994 | EP0591363A1 Pharmaceutical preparations containing torasemid |
| 04/13/1994 | EP0591355A1 Porphycene compounds for photodynamic therapy |
| 04/13/1994 | EP0591352A1 Topical application of steroid hormones and vaginocervical stimulation to induce maternal behaviour of animals |
| 04/13/1994 | EP0591346A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/13/1994 | EP0591311A1 Controlled release systems and low dose androgens |
| 04/13/1994 | EP0591303A1 Methods and compositions for treating malaria and other diseases |
| 04/13/1994 | EP0591280A1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists |
| 04/13/1994 | EP0591275A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| 04/13/1994 | EP0591256A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
| 04/13/1994 | EP0591254A1 Immunosuppressive and tolerogenic modified lewis?x and lewis?a compounds |
| 04/13/1994 | EP0591165A1 Heterocyclic steroid compounds |
| 04/13/1994 | EP0540580B1 Polymeric drug delivery system |
| 04/13/1994 | EP0446267B1 Hydroxamic acid based collagenase inhibitors |
| 04/13/1994 | EP0424504B1 NOVEL 9$g(a)-HYDROXY-3-OXO-4,24(25)-STIGMASTADIEN-26-OIC ACID DERIVATIVES, A PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 04/13/1994 | CN1085224A Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
| 04/13/1994 | CN1085223A 17beta-substituted 4-aza-5alpha-androstan-3-one derivatives |
| 04/13/1994 | CN1085217A 1,4-benzodioxane derivatives |
| 04/13/1994 | CN1085216A Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 04/13/1994 | CN1085214A Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these |
| 04/13/1994 | CN1085212A 吲哚衍生物 Indole derivatives |
| 04/13/1994 | CN1085211A Fluoride like vitamine D3 |
| 04/13/1994 | CN1085084A Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor |
| 04/13/1994 | CN1085083A Pharmaceuticals |
| 04/13/1994 | CN1085082A Vitamin E drop |
| 04/13/1994 | CN1085079A Antithyroid cream for external application |
| 04/13/1994 | CN1024198C Process for preparing adenosine derivatives |
| 04/13/1994 | CN1024197C Process for preparing acylated derivs. of etoposide |
| 04/13/1994 | CN1024193C Process for preparing oxaspiro |2.5¨ octane derivative |
| 04/13/1994 | CA2108093A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 04/13/1994 | CA2108060A1 Quinolonecarboxylic acids |
| 04/12/1994 | US5302727 Multidrug resistance modifying dithianes |
| 04/12/1994 | US5302724 Antitumor compositions and methods of treatment |
| 04/12/1994 | US5302721 Method of preparation of physostigmine carbamate derivatives from eseretholes |
| 04/12/1994 | US5302720 Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents |
| 04/12/1994 | US5302718 Compounds containing an amino salicylic acid moiety linked to a sulphapyridine moiety via stable bridge |
| 04/12/1994 | US5302716 Antipsychotic agents |
| 04/12/1994 | US5302712 Used for making pharmceutical compositions for treating infectious diseases |
| 04/12/1994 | US5302711 Deesterification of the blocked 3- or 4-carboxylate derivative of cepham or penam with lithium iodide in a nonbasic solvent having a dielectric constant of between 0 and 15 |
| 04/12/1994 | US5302706 Senescent cell derived inhibitors of DNA synthesis |
| 04/12/1994 | US5302705 6-O-methylerythromycin a oxime derivatives |
| 04/12/1994 | US5302621 Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use |
| 04/12/1994 | US5302617 Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds |
| 04/12/1994 | US5302611 Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same |
| 04/12/1994 | US5302609 Treatment of diabetic nephropathy |
| 04/12/1994 | US5302606 Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
| 04/12/1994 | US5302599 Therapeutically useful heterocyclic indole compounds |
| 04/12/1994 | US5302598 Administering an iron chelator and trimethoprim/sulfamethoxazole to treat and prevent AIDS-related pneumonia |
| 04/12/1994 | US5302597 Enzyme inhibitors |
| 04/12/1994 | US5302596 Tricyclic compounds as TXA2 antagonists |
| 04/12/1994 | US5302595 Muscarinic receptor antagonists |